PERCEPTIVE ADVISORS LLC Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for PERCEPTIVE ADVISORS LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PERCEPTIVE ADVISORS LLC. PERCEPTIVE ADVISORS LLC is a 10% Owner in LA JOLLA PHARMACEUTICAL CO ($LJPC) and a 10% Owner in VBI VACCINES INC. ($VBIV) and a in AMICUS THERAPEUTICS INC ($FOLD) and a 10% Owner in AMICUS THERAPEUTICS INC ($FOLD) and a 10% Owner in SCYNEXIS INC ($SCYX) and a in AGILE THERAPEUTICS INC ($AGRX) and a 10% Owner in AGILE THERAPEUTICS INC ($AGRX) and a 10% Owner in Athenex, Inc. ($ATNX) and a 10% Owner in ALBIREO PHARMA, INC. ($ALBO) and a Director in Lyra Therapeutics, Inc. ($LYRA) and a 10% Owner in VBI Vaccines Inc/BC ($VBIV) and a 10% Owner in Aldeyra Therapeutics, Inc. ($ALDX) and a 10% Owner in ADMA BIOLOGICS, INC. ($ADMA) and a 10% Owner in ZOGENIX, INC. ($ZGNX) and a 10% Owner in ACELRX PHARMACEUTICALS INC ($ACRX) and a Director in CATABASIS PHARMACEUTICALS INC ($CATB) and a 10% Owner in LEAP THERAPEUTICS, INC. ($LPTX) and a 10% Owner in Versartis, Inc. ($VSAR) and a in Kadmon Holdings, Inc. ($KDMN) and a 10% Owner in Menlo Therapeutics Inc. ($MNLO) and a 10% Owner in Corium International, Inc. ($CORI) and a 10% Owner in Quotient Ltd ($QTNT) and a 10% Owner in Athira Pharma, Inc. ($ATHA) and a Director in Athira Pharma, Inc. ($ATHA) and a 10% Owner in Global Blood Therapeutics, Inc. ($GBT) and a 10% Owner in Verrica Pharmaceuticals Inc. ($VRCA) and a 10% Owner in Crinetics Pharmaceuticals, Inc. ($CRNX) and a Director in Crinetics Pharmaceuticals, Inc. ($CRNX) and a 10% Owner in Dova Pharmaceuticals, Inc. ($DOVA) and a 10% Owner in Motus GI Holdings, Inc. ($MOTS) and a 10% Owner in Prometheus Biosciences, Inc. ($RXDX) and a 10% Owner in Rain Therapeutics Inc. ($RAIN) and a Director in Solid Biosciences Inc. ($SLDB) and a Director in MeiraGTx Holdings plc ($MGTX) and a Director in Landos Biopharma, Inc. ($LABP) and a Director in ARYA Sciences Acquisition Corp II ($ARYB).
Address: PERCEPTIVE CAPITAL 5437 CONNECTICUT AVENUE NW STE 100 WASHINGTON 20015 DC
Companies in which PERCEPTIVE ADVISORS LLC is an Insider
ACELRX PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PERCEPTIVE ADVISORS LLC: 10% Owner
Holdings: 4,533,728 shares
Current Value: $13,601,184
Latest Transaction: Jun 21 2017
$ACRX Market Capitalization: $131.47M
$ACRX Previous Close: $3.00
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ADMA BIOLOGICS, INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of PERCEPTIVE ADVISORS LLC: 10% Owner
Holdings: 16,584,802 shares
Current Value: $82,924,010
Latest Transaction: Mar 23 2020
$ADMA Market Capitalization: $63.82M
$ADMA Previous Close: $5.00
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
AGILE THERAPEUTICS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PERCEPTIVE ADVISORS LLC: 10% Owner
Holdings: 15,919,925 shares
Current Value: $37,730,222
Latest Transaction: Apr 06 2021
$AGRX Market Capitalization: $65.57M
$AGRX Previous Close: $2.37
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ALBIREO PHARMA, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PERCEPTIVE ADVISORS LLC: 10% Owner
Holdings: 2,360,139 shares
Latest Transaction: Sep 15 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Aldeyra Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PERCEPTIVE ADVISORS LLC: 10% Owner
Holdings: 8,703,879 shares
Current Value: $43,519,395
Latest Transaction: Jan 21 2021
$ALDX Market Capitalization: $30.29M
$ALDX Previous Close: $5.00
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
AMICUS THERAPEUTICS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PERCEPTIVE ADVISORS LLC: 10% Owner
Holdings: 20,694,424 shares
Current Value: $124,580,432
Latest Transaction: Oct 05 2018
$FOLD Market Capitalization: $869.61M
$FOLD Previous Close: $6.02
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Aravive, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PERCEPTIVE ADVISORS LLC: 10% Owner
Holdings: 4,102,984 shares
Current Value: $54,569,687
Latest Transaction: Sep 25 2017
$ARAV Market Capitalization: $474.95M
$ARAV Previous Close: $13.30
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Athenex, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PERCEPTIVE ADVISORS LLC: 10% Owner
Holdings: 11,732,467 shares
Latest Transaction: Sep 14 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Athira Pharma, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of PERCEPTIVE ADVISORS LLC: Director, 10% Owner
Holdings: 3,425,916 shares
Latest Transaction: Jun 01 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CATABASIS PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PERCEPTIVE ADVISORS LLC: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Feb 03 2021
$CATB Market Capitalization: $22.76M
$CATB Previous Close: $1.23
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Cerevel Therapeutics Holdings, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PERCEPTIVE ADVISORS LLC: Director
Holdings: 114,100 shares
Latest Transaction: Oct 22 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Corium International, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PERCEPTIVE ADVISORS LLC: 10% Owner
Holdings: 6,074,686 shares
Current Value: $17,191,361
Latest Transaction: Oct 15 2018
$CORI Market Capitalization: $63.69M
$CORI Previous Close: $2.83
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Crinetics Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PERCEPTIVE ADVISORS LLC: 10% Owner, Director
Holdings: 3,659,381 shares
Latest Transaction: Apr 20 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Dova Pharmaceuticals Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PERCEPTIVE ADVISORS LLC: 10% Owner
Holdings: 0 shares
Latest Transaction: Nov 15 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Global Blood Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PERCEPTIVE ADVISORS LLC: 10% Owner
Holdings: 4,889,066 shares
Current Value: $79,202,869
Latest Transaction: Dec 19 2017
$GBT Market Capitalization: $626.91M
$GBT Previous Close: $16.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Kadmon Holdings, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PERCEPTIVE ADVISORS LLC:
Holdings: 14,636,334 shares
Current Value: $58,398,973
Latest Transaction: Nov 18 2019
$KDMN Market Capitalization: $176.71M
$KDMN Previous Close: $3.99
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
LA JOLLA PHARMACEUTICAL CO
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of PERCEPTIVE ADVISORS LLC: 10% Owner
Holdings: 3,881,967 shares
Current Value: $75,581,897
Latest Transaction: Jan 09 2019
$LJPC Market Capitalization: $355.22M
$LJPC Previous Close: $19.47
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Landos Biopharma, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PERCEPTIVE ADVISORS LLC: Director
Holdings: 7,077,017 shares
Latest Transaction: Feb 09 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
LEAP THERAPEUTICS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PERCEPTIVE ADVISORS LLC: 10% Owner
Holdings: 8,476,496 shares
Latest Transaction: Jun 24 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Lyra Therapeutics, Inc.
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of PERCEPTIVE ADVISORS LLC: Director
Holdings: 1,934,115 shares
Latest Transaction: May 29 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
MeiraGTx Holdings plc
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of PERCEPTIVE ADVISORS LLC: Director
Holdings: 6,433,277 shares
Latest Transaction: Jun 04 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Motus GI Holdings, Inc.
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of PERCEPTIVE ADVISORS LLC: 10% Owner
Holdings: 3,884,894 shares
Latest Transaction: Jan 22 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Prometheus Biosciences, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PERCEPTIVE ADVISORS LLC: 10% Owner
Holdings: 1,017,770 shares
Latest Transaction: Mar 16 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Quotient Ltd
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of PERCEPTIVE ADVISORS LLC: 10% Owner
Holdings: 16,200,818 shares
Current Value: $107,735,440
Latest Transaction: Sep 16 2020
$QTNT Market Capitalization: $99.91M
$QTNT Previous Close: $6.65
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Rain Therapeutics Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PERCEPTIVE ADVISORS LLC: 10% Owner
Holdings: 879,703 shares
Latest Transaction: Apr 27 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
SCYNEXIS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PERCEPTIVE ADVISORS LLC: 10% Owner
Holdings: 2,215,000 shares
Current Value: $6,977,250
Latest Transaction: Jan 26 2021
$SCYX Market Capitalization: $82.53M
$SCYX Previous Close: $3.15
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Solid Biosciences Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of PERCEPTIVE ADVISORS LLC: Director
Holdings: 13,412,552 shares
Latest Transaction: Mar 23 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
VBI VACCINES INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of PERCEPTIVE ADVISORS LLC: 10% Owner
Holdings: 6,213,314 shares
Current Value: $25,412,454
Latest Transaction: Dec 08 2016
$VBIV Market Capitalization: $149.16M
$VBIV Previous Close: $4.09
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
VBI Vaccines Inc/BC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PERCEPTIVE ADVISORS LLC: 10% Owner
Holdings: 55,042,456 shares
Latest Transaction: Apr 28 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Verrica Pharmaceuticals Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PERCEPTIVE ADVISORS LLC: 10% Owner
Holdings: 1,130,679 shares
Latest Transaction: Aug 01 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
VYNE Therapeutics Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PERCEPTIVE ADVISORS LLC: 10% Owner
Holdings: 5,773,954 shares
Latest Transaction: May 07 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ZOGENIX, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PERCEPTIVE ADVISORS LLC: 10% Owner
Holdings: 4,070,357 shares
Current Value: $34,598,035
Latest Transaction: Aug 14 2018
$ZGNX Market Capitalization: $228.07M
$ZGNX Previous Close: $8.50
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of PERCEPTIVE ADVISORS LLC
Sentiment: All, ACRX, ADMA, AGRX, ALBO, ALDX, FOLD, ARAV, ATNX, ATHA, CATB, CERE, CORI, CRNX, DOVA, GBT, KDMN, LJPC, LABP, LPTX, LYRA, MGTX, MOTS, RXDX, QTNT, RAIN, SCYX, SLDB, VBIV, VBIV, VRCA, MNLO, ZGNX
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 01 2021 | ATHA | Athira Pharma, Inc ... | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | A | 19.94 | 13,871 | 276,588 | 13,871 | |
| May 07 2021 | MNLO | VYNE Therapeutics ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | S | 3.67 | 1,000,000 | 3,670,000 | 5,773,954 | 6.8 M to 5.8 M (-14.76 %) |
| Apr 27 2021 | RAIN | Rain Therapeutics ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 1,195,792 | 0 | 0 | |
| Apr 27 2021 | RAIN | Rain Therapeutics ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 949,992 | 0 | 0 | |
| Apr 27 2021 | RAIN | Rain Therapeutics ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 17.00 | 550,000 | 9,350,000 | 2,537,019 | 2 M to 2.5 M (+27.68 %) |
| Apr 27 2021 | RAIN | Rain Therapeutics ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 1,107,316 | 0 | 1,987,019 | 879.7 K to 2 M (+125.87 %) |
| Apr 27 2021 | RAIN | Rain Therapeutics ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 879,703 | 0 | 879,703 | 0 to 879.7 K |